Literature DB >> 11022854

Mitochondrial ND1 sequence analysis and association of the T4216C mutation with Parkinson's disease.

S C Kirchner1, S E Hallagan, F M Farin, J Dilley, P Costa-Mallen, T Smith-Weller, G M Franklin, P D Swanson, H Checkoway.   

Abstract

Mitochondrial dysfunction originating from mutations in Complex I genes may play a role in the pathogenesis of Parkinson's disease (PD). In this study, the entire ND1 coding sequence was sequenced in 84 newly diagnosed PD cases and 127 age/gender-matched controls. Numerous missense mutations were found at low frequency (<5%), whereas a thymidine to cytosine missense mutation at position 4216 that results in the replacement of tyrosine with histidine was found in 25% of the PD case samples and in 18% of the controls. When calculated according to gender, the 4216 mutation was observed in 26% of the male cases versus 16% of male controls (Odds Ratio [OR] = 1.85; 95% CI = 0.79-4.34). In contrast, females exhibited approximately equal frequencies among cases (22.5%) and controls (21%), yielding an OR of 1.08 (95% C.I. = 0.36-3.22). The findings indicate only a weak association of this genetic variant with PD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11022854

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  8 in total

1.  Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease.

Authors:  Russell H Swerdlow; Bradley Weaver; Amy Grawey; Connie Wenger; Eric Freed; Bradford B Worrall
Journal:  J Neurol Sci       Date:  2006-06-19       Impact factor: 3.181

Review 2.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

3.  Mitochondrial polymorphisms impact outcomes after severe traumatic brain injury.

Authors:  Yvette P Conley; David O Okonkwo; Sandra Deslouches; Sheila Alexander; Ava M Puccio; Sue R Beers; Dianxu Ren
Journal:  J Neurotrauma       Date:  2013-11-14       Impact factor: 5.269

4.  Genotyping Parkinson disease-associated mitochondrial polymorphisms.

Authors:  Yiguo Jiang; Tammy Ellis; Anne R Greenlee
Journal:  Clin Med Res       Date:  2004-05

Review 5.  Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

Review 6.  Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes.

Authors:  Lisa Mosconi; Valentina Berti; Russell H Swerdlow; Alberto Pupi; Ranjan Duara; Mony de Leon
Journal:  Hum Genomics       Date:  2010-02       Impact factor: 4.639

Review 7.  The Role of Mitochondria in Carcinogenesis.

Authors:  Paulina Kozakiewicz; Ludmiła Grzybowska-Szatkowska; Marzanna Ciesielka; Jolanta Rzymowska
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

8.  Next-generation sequencing identifies novel mitochondrial variants in pituitary adenomas.

Authors:  K Németh; O Darvasi; I Likó; N Szücs; S Czirják; L Reiniger; B Szabó; P A Kurucz; L Krokker; P Igaz; A Patócs; H Butz
Journal:  J Endocrinol Invest       Date:  2019-01-25       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.